Effects on hepatocellular carcinoma of doxorubicin-loaded immunoliposomes designed to target VEGFR-2 - Roth,P.; Hammer,C.; Piguet,A.C.; Ledermann,M.; Dufour,J.F.; Waelti,E. (J Drug Target, 2007)